AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push
The acquisition, one of the largest biotech deals of the year, underscores the surge in pharmaceutic…
Curated articles across 9 categories — stay informed, stay curious.
The acquisition, one of the largest biotech deals of the year, underscores the surge in pharmaceutic…
 Israel kills turtl…
CRH is offering $150 per share for Arcosa, representing a 10.4% premium to Arcosa's last close. Arco…
ASML is likely to outperform as its semiconductor fabrication business sees an influx of orders due …
- Alan Greenspan presided over the Federal Reserve for 19 years under four presidents, from Presiden…
![INTERACTIVE - PM outside-1782120836](/wp-content/uploads/2026/06/INTERACTIVE-PM-outside-1782120836…
![Coca-Cola](/wp-content/uploads/2026/06/AP24215793546555-1782106303.jpg?resize=770%2C513&quality=80…
It’s Monday again. This week’s threat list looks painfully familiar: abused integrations, fake tools…
Ovintiv shares have been under pressure of late, but they could soon bounce following the energy com…
![British Prime Minister Keir Starmer stands next to his wife Victoria.](/wp-content/uploads/2026/06…
![WASHINGTON, DC - JUNE 18: Vice President J.D. Vance speaks during a news conference in the Brady P…
Advertisement